{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:29:56Z","timestamp":1777465796559,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.4158\/ep-2019-0407","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T21:20:39Z","timestamp":1592947239000},"page":"1003-1016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Role of Androgen in Liver Fat Content in Women: Metabolically Advantageous or Disadvantageous?"],"prefix":"10.1016","volume":"26","author":[{"given":"Yuying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0407_bb0010","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0407_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/der396","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS)","volume":"27","author":"Fauser","year":"2012","journal-title":"Hum Reprod."},{"key":"10.4158\/EP-2019-0407_bb0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"New Engl J Med."},{"key":"10.4158\/EP-2019-0407_bb0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update."},{"key":"10.4158\/EP-2019-0407_bb0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annu Rev Physiol."},{"key":"10.4158\/EP-2019-0407_bb0035","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology."},{"key":"10.4158\/EP-2019-0407_bb0040","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease","volume":"20","author":"Paradies","year":"2014","journal-title":"World J Gastroentero."},{"key":"10.4158\/EP-2019-0407_bb0045","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/gutjnl-2015-311292","article-title":"Epigenetics in liver disease: from biology to therapeutics","volume":"65","author":"Hardy","year":"2016","journal-title":"Gut."},{"key":"10.4158\/EP-2019-0407_bb0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/hepr.12658","article-title":"Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors","volume":"46","author":"Akazawa","year":"2016","journal-title":"Hepatol Res."},{"key":"10.4158\/EP-2019-0407_bb0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1210\/en.2016-1553","article-title":"Low-dose dihydrotestosterone drives metabolic dysfunction via cytosolic and nuclear hepatic androgen receptor mechanisms","volume":"158","author":"Andrisse","year":"2017","journal-title":"Endocrinology."},{"key":"10.4158\/EP-2019-0407_bb0060","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology."},{"key":"10.4158\/EP-2019-0407_bb0065","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0407_bb0070","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int J Obes."},{"key":"10.4158\/EP-2019-0407_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-230X-12-69","article-title":"A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease","volume":"12","author":"Kim","year":"2012","journal-title":"Bmc Gastroenterol."},{"key":"10.4158\/EP-2019-0407_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2605.2009.00953.x","article-title":"Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men","volume":"33","author":"V\u00f6lzke","year":"2010","journal-title":"Int J Androl."},{"key":"10.4158\/EP-2019-0407_bb0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1179\/2045772314Y.0000000288","article-title":"Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury","volume":"39","author":"Barbonetti","year":"2016","journal-title":"J Spinal Cord Med."},{"key":"10.4158\/EP-2019-0407_bb0090","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1530\/EJE-17-0124","article-title":"Mechanisms in endocrinology: The sexually dimorphic role of androgens in human metabolic disease","volume":"177","author":"Schiffer","year":"2017","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP-2019-0407_bb0095","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/diacare.23.7.912","article-title":"Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women","volume":"23","author":"Goodman-Gruen","year":"2000","journal-title":"Diabetes Care."},{"key":"10.4158\/EP-2019-0407_bb0100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology."},{"key":"10.4158\/EP-2019-0407_bb0105","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"New Engl J Med."},{"key":"10.4158\/EP-2019-0407_bb0110","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/oby.21182","article-title":"Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases","volume":"23","author":"Xia","year":"2015","journal-title":"Obesity."},{"key":"10.4158\/EP-2019-0407_bb0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature."},{"key":"10.4158\/EP-2019-0407_bb0120","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"Marchesini","year":"2016","journal-title":"J Hepatol."},{"key":"10.4158\/EP-2019-0407_bb0125","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/oby.2011.302","article-title":"Standardized ultrasound hepatic\/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method","volume":"20","author":"Xia","year":"2012","journal-title":"Obesity."},{"key":"10.4158\/EP-2019-0407_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Fauser","year":"2004","journal-title":"Hum Reprod."},{"key":"10.4158\/EP-2019-0407_bb0135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","journal-title":"Hum Reprod."},{"key":"10.4158\/EP-2019-0407_bb0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"47","author":"Cerda","year":"2007","journal-title":"J Hepatol."},{"key":"10.4158\/EP-2019-0407_bb0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/uog.10084","article-title":"Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome","volume":"39","author":"Zueff","year":"2012","journal-title":"Ultrasound Obst Gyn."},{"key":"10.4158\/EP-2019-0407_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0974-1208.112370","article-title":"Prevalence of hepatic steatosis in women with polycystic ovary syndrome","volume":"6","author":"Karoli","year":"2013","journal-title":"J Hum Reprod Sci."},{"key":"10.4158\/EP-2019-0407_bb0155","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.cgh.2014.12.033","article-title":"Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis","volume":"13","author":"Lazo","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.4158\/EP-2019-0407_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2017.05.002","article-title":"Polycystic ovary syndrome: understanding the role of the brain","volume":"46","author":"Moore","year":"2017","journal-title":"Front Neuroendocrin."},{"key":"10.4158\/EP-2019-0407_bb0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jsbmb.2013.04.001","article-title":"Androgen (dihydrotestosterone)-mediated regulation of food intake and obesity in female mice","volume":"138","author":"Kanaya","year":"2013","journal-title":"J Steroid Biochem."},{"key":"10.4158\/EP-2019-0407_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.abb.2017.03.007","article-title":"Abnormal lipid\/lipoprotein metabolism and high plasma testosterone levels in male but not female aromatase-knockout mice","volume":"622","author":"Amano","year":"2017","journal-title":"Arch Biochem Biophys."},{"key":"10.4158\/EP-2019-0407_bb0175","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science."},{"key":"10.4158\/EP-2019-0407_bb0180","doi-asserted-by":"crossref","first-page":"E848","DOI":"10.1210\/jc.2013-4109","article-title":"Hyperandrogenism induces a proinflammatory TNF alpha response to glucose ingestion in a receptor-dependent fashion","volume":"99","author":"Gonz\u00e1lez","year":"2014","journal-title":"J Clin Endocr Metab."},{"key":"10.4158\/EP-2019-0407_bb0185","first-page":"E297","article-title":"Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women","volume":"302","author":"Gonz\u00e1lez","year":"2012","journal-title":"Am J Physiol-Endoc M."},{"key":"10.4158\/EP-2019-0407_bb0190","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3748\/wjg.v20.i26.8351","article-title":"Nonalcoholic fatty liver disease and polycystic ovary syndrome","volume":"20","author":"Vassilatou","year":"2014","journal-title":"World J Gastroentero."},{"key":"10.4158\/EP-2019-0407_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-019-02085-7","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"67","author":"Paschou","year":"2020","journal-title":"Endocrine."},{"key":"10.4158\/EP-2019-0407_bb0200","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1042\/CS20170987","article-title":"Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?","volume":"131","author":"Gastaldelli","year":"2017","journal-title":"Clin Sci."},{"key":"10.4158\/EP-2019-0407_bb0205","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2337\/diabetes.52.2.260","article-title":"Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis","volume":"52","author":"Staehr","year":"2003","journal-title":"Diabetes."},{"key":"10.4158\/EP-2019-0407_bb0210","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev."},{"key":"10.4158\/EP-2019-0407_bb0215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11154-007-9054-0","article-title":"The adrenal and polycystic ovary syndrome","volume":"8","author":"Yildiz","year":"2007","journal-title":"Rev Endocr Metab Dis."},{"key":"10.4158\/EP-2019-0407_bb0220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1479-5876-11-133","article-title":"Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS)","volume":"11","author":"Baranova","year":"2013","journal-title":"J Transl Med."},{"key":"10.4158\/EP-2019-0407_bb0225","doi-asserted-by":"crossref","first-page":"18073","DOI":"10.1074\/jbc.M414231200","article-title":"Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes","volume":"280","author":"Xu","year":"2005","journal-title":"J Biol Chem."},{"key":"10.4158\/EP-2019-0407_bb0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.metabol.2010.09.003","article-title":"Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"60","author":"Polyzos","year":"2011","journal-title":"Metabolism."},{"key":"10.4158\/EP-2019-0407_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2018.06.013","article-title":"Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome","volume":"116","author":"Vassilatou","year":"2018","journal-title":"Maturitas."},{"key":"10.4158\/EP-2019-0407_bb0240","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.ogx.0000197817.93201.04","article-title":"Polycystic ovary syndrome and its differential diagnosis","volume":"61","author":"Lane","year":"2006","journal-title":"Obstet Gynecol Surv."},{"key":"10.4158\/EP-2019-0407_bb0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Fauser","year":"2004","journal-title":"Hum Reprod."},{"key":"10.4158\/EP-2019-0407_bb0250","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology."},{"key":"10.4158\/EP-2019-0407_bb0255","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0407_bb0260","author":"Free & bioavailable testosterone calculator","year":"2020"},{"key":"10.4158\/EP-2019-0407_bb0265","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0407_bb0270","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment - insulin resistance and beta-cell function from fasting plasma-glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia."},{"key":"10.4158\/EP-2019-0407_bb0275","first-page":"777","article-title":"Early impaired beta-cell function in chinese women with polycystic ovary syndrome","volume":"5","author":"Tao","year":"2012","journal-title":"Int J Clin Exp Patho."},{"key":"10.4158\/EP-2019-0407_bb0280","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis and classification of diabetes mellitus - provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabetic Med."},{"key":"10.4158\/EP-2019-0407_bb0285","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","author":"Grundy","year":"2002","journal-title":"Circulation."},{"key":"10.4158\/EP-2019-0407_bb0290","first-page":"182","article-title":"The diagnostic significance of homeostasis model assessment of insulin resistance in metabolic syndrome among subjects with different glucose tolerance","volume":"2","author":"Xiao-yan","year":"2004","journal-title":"Chin J Diabetes."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20482254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20482254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:09:17Z","timestamp":1761516557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20482254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1530891X20482254"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0407","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Androgen in Liver Fat Content in Women: Metabolically Advantageous or Disadvantageous?","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}